TrialTrials2017

Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial.

Jun-Bean Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.